Dyslipidemia in diabetic kidney disease classified by proteinuria and renal dysfunction: A cross-sectional study from a regional diabetes cohort
Journal of Diabetes Investigation Nov 10, 2021
Hirano T, Satoh N, Kodera R, et al. - Proteinuria was identified to be linked with an atherogenic subspecies of low-density lipoprotein (LDL), whereas elevated lipoprotein(a) was detected in relation to renal dysfunction. Exacerbation of triglyceride (TG)-rich lipoprotein-related dyslipidemia was independently induced by both proteinuria and renal dysfunction. This is in good agreement with findings from large-scale clinical studies wherein risk of atherosclerotic cardiovascular disease in diabetics was synergistically elevated by proteinuria and renal dysfunction.
Study of 1,073 diabetes patients enrolled in the regional diabetes cohort (ViNA cohort), to investigate dyslipidemia in different diabetic kidney disease (DKD) phenotypes that have not been fully examined.
Higher proportion of atherosclerotic cardiovascular disease patients was identified in non-proteinuric DKD and even higher in proteinuric DKD vs non-DKD.
There existed independent correlations of increased estimated glomerular filtration rate grade and albuminuric stage with higher TG, TG-rich lipoprotein cholesterol and apolipoprotein CIII, thus, the highest of these levels were detected in proteinuric DKD.
The proteinuria without renal dysfunction group exhibited higher small dense LDL cholesterol and LDL-TG, in the lipid-lowering drug-free subset.
Irrespective of proteinuria, higher lipoprotein(a) was detected in DKD.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries